SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-17-000037
Filing Date
2017-03-06
Accepted
2017-03-06 16:02:20
Documents
1
Period of Report
2017-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148883412602740.html 4  
1 FORM 4 wf-form4_148883412602740.xml 4 4496
  Complete submission text file 0000920465-17-000037.txt   5755
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 17667853